Australian Medical Device Framework Takes Effect; Reuse Is On Horizon
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of the 20% of CE-marked Class I, Class IIa and Class IIb devices randomly selected to undergo an audit by Australia's Therapeutic Goods Administration will pay additional fees under the country's new medical device framework, which took effect Oct. 4
You may also be interested in...
SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA
Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration
SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA
Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration
Device Modification Review Times Fall Behind In Canada, Australia, Japan
Manufacturers having difficulty defining "substantial change" when determining whether to submit product modification plans to regulatory authorities should formalize their internal decision-making processes, according to Guidant Regulatory Affairs Manager Gayle Johnson